Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.8 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Opioid antagonists; dispensing and administration by person acting on behalf of an organization. | Opioid antagonists; dispensing and administration by person acting on behalf of an organization. Permits persons acting on behalf of an organization that provides services to individuals at risk of experiencing an opioid overdose or training in the administration of naloxone or other opioid antagonists to dispense other opioid antagonists. The bill also allows persons to whom other opioid antagonists are dispensed to possess and administer such opioid antagonists. Under current law, persons acting on behalf of such organizations may only dispense naloxone. This bill incorporates SB 790 and is identical to HB 1637. | us/states/va | Virginia General Assembly | 2025 | SB 1035 | Virginia SB 1035 (2025) |
|
enacted |
|
4 | 33 | 5 | 2025-01-07 | 2025-03-24 | openstates | ocd-bill/46cd4bbb-8599-470c-8550-fb833be14bfd | https://lis.virginia.gov/bill-details/20251/SB1035 | 1d25ac15746a621a9902e8030d27dcfc46f957bfa14c5b3507a00dbfa48bdea2 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 1035 (2025) — Opioid antagonists; dispensing and administration by person acting on behalf of an organization.
Opioid antagonists; dispensing and administration by person acting on behalf of an organization. Permits persons acting on behalf of an organization that provides services to individuals at risk of experiencing an opioid overdose or training in the administration of naloxone or other opioid antagonists to dispense other opioid antagonists. The bill also allows persons to whom other opioid antagonists are dispensed to possess and administer such opioid antagonists. Under current law, persons acting on behalf of such organizations may only dispense naloxone. This bill incorporates SB 790 and is identical to HB 1637.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Introduced (filed) — source
- Chaptered (committee substitute) — source
- Education and Health Substitute (committee substitute) — source
- Enrolled (enrolled) — source
Votes
- Passed House (91-Y 3-N) — 91–3 (pass) · lower
- Read third time and passed Senate (39-Y 0-N) — 39–0 (pass) · upper
- Reported from Education and Health with substitute (15-Y 0-N) — 15–0 (pass) · upper
- Reported from Health and Human Services (21-Y 1-N) — 21–1 (pass) · lower
- Constitutional reading dispensed (on 1st reading) (37-Y 0-N) — 37–0 (pass) · upper
Sponsors
- Stella G. Pekarsky — primary (person)
- Christopher T. Head — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2025-01-07 Prefiled and ordered printed; Offered 01-08-2025 25102390D
filing, introduction - 2025-01-07 Referred to Committee on Education and Health
referral-committee - 2025-01-14 Fiscal Impact Statement from Department of Planning and Budget (SB1035)
- 2025-01-17 Assigned Education sub: Health Professions
referral-committee - 2025-01-23 Incorporates SB790(Head)
- 2025-01-23 Reported from Education and Health with substitute (15-Y 0-N)
committee-passage - 2025-01-23 Committee substitute printed 25105819D-S1
substitution - 2025-01-24 Rules suspended
- 2025-01-24 Constitutional reading dispensed (on 1st reading) (37-Y 0-N)
- 2025-01-24 Passed by for the day
- 2025-01-26 Fiscal Impact Statement from Department of Planning and Budget (SB1035)
- 2025-01-27 Read second time
reading-2 - 2025-01-27 Reading of substitute waived
- 2025-01-27 Education and Health Substitute agreed to
- 2025-01-27 Engrossed by Senate - committee substitute
substitution - 2025-01-28 Read third time and passed Senate (39-Y 0-N)
passage, reading-3 - 2025-02-03 Placed on Calendar
- 2025-02-03 Read first time
reading-1 - 2025-02-03 Referred to Committee on Labor and Commerce
referral-committee - 2025-02-06 Referred from Labor and Commerce and referred to Health and Human Services (Voice Vote)
referral-committee - 2025-02-11 Reported from Health and Human Services (21-Y 1-N)
committee-passage - 2025-02-13 Read second time
reading-2 - 2025-02-14 Read third time
reading-3 - 2025-02-14 Passed House (91-Y 3-N)
passage - 2025-02-18 Enrolled
enrolled - 2025-02-18 Bill text as passed Senate and House (SB1035ER)
passage - 2025-02-18 Fiscal Impact Statement from Department of Planning and Budget (SB1035)
- 2025-02-18 Signed by Speaker
passage - 2025-02-20 Signed by President
passage - 2025-03-03 Enrolled Bill Communicated to Governor on March 3, 2025
enrolled - 2025-03-03 Governor's Action Deadline 11:59 p.m., March 24, 2025
executive-receipt - 2025-03-24 Approved by Governor-Chapter 386 (Effective 07/01/25)
executive-signature - 2025-03-24 Acts of Assembly Chapter text (CHAP0386)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/46cd4bbb-8599-470c-8550-fb833be14bfd. Confidence: reported (aggregated from official Virginia legislature records).